Research and development (R&D) investment in the Swiss biotech sector grew in 2024, despite ongoing global funding struggles. While many countries have seen a decline in investment in recent years ...

The biotechnology company BeiGene, founded in China, is moving its legal headquarters from the Cayman Islands to Basel.

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

At a recent gathering, experts in the Swiss biotech and pharma sector underscored the power of international collaboration.

Despite the slowdown in dealmaking, French drugmaker Sanofi on Monday agreed to buy immunology-focused biotech Blueprint Medicines in a deal worth up to $9.5bn and Bristol Myers Squibb struck an up to ...

For decades, things went well for Bellevue Group. But now the sector weakness in biotechs could lead to losses.

Merck has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than $3 billion, the Financial Times reported ...

At a time when investment has been low in biotech, establishing and maintaining good relationships with investors is vital.

The biotech – which was incubated by Swiss investment group Xlife Sciences – is also planning an additional financing round to top up its cash reserves even further as it works towards ...

BERLIN, April 23 (Reuters) - Swiss biotech investor Xlife Sciences AG (XLS.S), opens new tab said on Wednesday its portfolio company Veraxa Biotech AG would list on U.S. exchange Nasdaq in a $1.64 ...

The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested it may try to equalize through tariffs.